FDA Drug · D-0254-2026

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Class II · Ongoing

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Affected lots / codes — check yours against thisLot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027.

Recalling firm: SpecGx, LLC, Webster Groves, MO
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 287,988 Bottles.
Distribution: Nationwide
Recall initiated: December 16, 2025
Classified: January 7, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0254-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →